从微小残留病角度看白血病诊疗

Progress on diagnosis and treatment of leukemia from the perspective of minimal residual disease

微小残留病(MRD)是评估白血病疗效的重要参数之一,与患者治疗后的复发和生存密切相关。文章结合第62届美国血液学会(ASH)年会MRD评估预后和指导治疗选择方面的代表性报道,从MRD角度总结了白血病的诊疗新进展。

Minimal residual disease(MRD)is one of the important variables to evaluate the outcomes of patients with leukemia,which is related to the relapse and survival of patients after treatment.This article summarizes the new progress on diagnosis and treatment of leukemia from the perspective of MRD in combination with some representative studies on MRD⁃based prognostic assessment and guidance on treatment options that were reported at the 62nd American Society of Hematology(ASH)Annual Meeting.